• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CDI BLOOD PARAMETER MONITORING SYSTEM 550; CARDIOPULMONARY BYPASS ON-LINE BLOOD GAS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CDI BLOOD PARAMETER MONITORING SYSTEM 550; CARDIOPULMONARY BYPASS ON-LINE BLOOD GAS Back to Search Results
Model Number 550AHCT
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, the venous oxygen saturation (svo2) displayed a higher than expected pre-in-vivo.As a mitigation an in-vivo calibration was performed.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the patient.Per clinical review: the manufacturer's clinical specialist spoke with the perfusionist about the concern he had with the blood parameter monitor (bpm) svo2 readings on the new bpm versus what he was used to seeing on the old bpm svo2 pre-in-vivo.During three previous procedures before the informed date of february 3, 2020, the team stated that the svo2 values were reading different compared to the old bpm and were on the higher side.The clinical specialist conferred with the software team of the difference in expected pre-in-vivo values from the two devices and discussed this with the perfusionist.The perfusionist was informed that the expected/listed accuracy values are post the first in-vivo and all decisions should be made with confirmation from a blood gas analyzer.He stated post in-vivo the values followed as expected.There was no blood loss on these procedures.There was no harm or delay in the continuation of the surgical procedures.The question from the user was a usability/clinical question that was appropriately answered.
 
Manufacturer Narrative
The reported complaint was confirmed.The issue was observed prior to an in-vivo calibration.After the user calibrated, post in-vivo, the values were accurate and the unit operated as intended.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CDI BLOOD PARAMETER MONITORING SYSTEM 550
Type of Device
CARDIOPULMONARY BYPASS ON-LINE BLOOD GAS
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
6200 jackson road
ann arbor MI 48103
MDR Report Key9769037
MDR Text Key199877247
Report Number1828100-2020-00092
Device Sequence Number1
Product Code DRY
Combination Product (y/n)N
PMA/PMN Number
K182110
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 04/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number550AHCT
Device Catalogue Number550AHCT
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/03/2020
Initial Date FDA Received02/28/2020
Supplement Dates Manufacturer Received03/12/2020
04/07/2020
Supplement Dates FDA Received04/02/2020
04/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-